HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth Silver Selected Research

Ataxia (Dyssynergia)

8/2017Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth Silver Research Topics

Disease

1Hemiplegia (Spastic Hemiplegia)
11/2018
1Ataxia (Dyssynergia)
08/2017
1Cerebellar Ataxia (Dysmetria)
08/2017
1Brain Diseases (Brain Disorder)
08/2017
1Alternating hemiplegia of childhood
01/2015
1Dystonia 12
09/2012
1Encephalitis (Encephalitis, Rasmussen)
01/2012
1Psychotic Disorders (Schizoaffective Disorder)
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2011
1Menkes Kinky Hair Syndrome (Menkes Disease)
11/2011
1Neuromyelitis Optica (Devic's Disease)
02/2011
1Dyskinesias (Dyskinesia)
05/2009
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
11/2007
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
04/2007
1Muscular Dystrophies (Muscular Dystrophy)
04/2007
1Seizures (Absence Seizure)
10/2002
1Drug Resistant Epilepsy
10/2002
1Ring Chromosome 20 Syndrome
10/2002

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
08/2017 - 04/2007
2Adenosine Triphosphatases (ATPase)IBA
01/2015 - 09/2012
1bis(cyclohexylammonium)sulfateIBA
11/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012
1CopperIBA
11/2011
1Rituximab (Mabthera)FDA Link
02/2011
1N-acetylglucosamine-6-sulfataseIBA
11/2007
1EnzymesIBA
11/2007
1Heparitin Sulfate (Heparan Sulfate)IBA
11/2007
1DystrophinIBA
04/2007
1Glycoproteins (Glycoprotein)IBA
04/2007

Therapy/Procedure

1Pallidotomy
05/2009
1Vagus Nerve Stimulation
10/2002
1Therapeutics
10/2002